| MTCAX | SCIRX | MTCAX / SCIRX | |
| Total Expense Ratio | 1.11 | 1.41 | 79% |
| Annual Report Gross Expense Ratio | 1.12 | 1.41 | 79% |
| Fund Existence | 30 years | 23 years | - |
| Gain YTD | 13.236 | 46.033 | 29% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.3B | 27.5B | 8% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 4.84 | 64.29 | 8% |
| Returns for 3 years | 34.52 | 99.22 | 35% |
| Returns for 5 years | -4.25 | 70.46 | -6% |
| Returns for 10 years | 154.17 | 263.14 | 59% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AAAA | 30.03 | 0.15 | +0.49% |
| Amplius Aggressive Asset Allocation ETF | |||
| DON | 57.52 | -0.05 | -0.09% |
| WisdomTree US MidCap Dividend ETF | |||
| AVSD | 81.18 | -0.50 | -0.62% |
| Avantis Responsible International Eq ETF | |||
| LIAU | 252.82 | -3.16 | -1.23% |
| LifeX 2060 Infl-Prt Longevity Income ETF | |||
| GNOM | 54.17 | -1.22 | -2.21% |
| Global X Genomics & Biotechnology ETF | |||